A systematic literature review of the economic and healthcare resource burden of cytomegalovirus

References

• Taylor GH. Cytomegalovirus. Am Fam Physician. 2003;67:519–524.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Congenital CMV infection. [cited 2022 Sep 19]. Available from: https://www.cdc.gov/cmv/clinical/congenital-cmv.html.
   Google Scholar
• Zuhair M, Smit GSA, Wallis G, et al. Estimation of the worldwide seroprevalence of cytomegalovirus: a systematic review and meta-analysis. Rev Med Virol. 2019;29(3):e2034. doi: 10.1002/rmv.2034.
   PubMed Web of Science ®Google Scholar
• Cannon MJ, Hyde TB, Schmid DS. Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol. 2011;21(4):240–255. doi: 10.1002/rmv.695.
   PubMed Web of Science ®Google Scholar
• Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17(4):253–276. doi: 10.1002/rmv.535.
   PubMed Web of Science ®Google Scholar
• Manicklal S, Emery VC, Lazzarotto T, et al. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26(1):86–102. doi: 10.1128/CMR.00062-12.
   PubMed Web of Science ®Google Scholar
• Kabani N, Ross SA. Congenital cytomegalovirus infection. J Infect Dis. 2020;221(Suppl 1):S9–S14. doi: 10.1093/infdis/jiz446.
   PubMed Web of Science ®Google Scholar
• Pass RF, Arav-Boger R. Maternal and fetal cytomegalovirus infection: diagnosis, management, and prevention. F1000Res. 2018;7:255. doi: 10.12688/f1000research.12517.1.
   PubMedGoogle Scholar
• Boppana SB, Ross SA, Fowler KB. Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis. 2013;57(suppl 4):S178–S181. doi: 10.1093/cid/cit629.
   PubMed Web of Science ®Google Scholar
• Gantt S, Bitnun A, Renaud C, et al. Diagnosis and management of infants with congenital cytomegalovirus infection. Paediatr Child Health. 2017;22(2):72–74. doi: 10.1093/pch/pxx002.
   PubMed Web of Science ®Google Scholar
• Rawlinson WD, Boppana SB, Fowler KB, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017;17(6):e177–e188. doi: 10.1016/S1473-3099(17)30143-3.
   PubMed Web of Science ®Google Scholar
• Kotton CN, Kumar D, Caliendo AM, et al. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation. 2018;102(6):900–931. doi: 10.1097/TP.0000000000002191.
   PubMed Web of Science ®Google Scholar
• Hakki M, Aitken SL, Danziger-Isakov L, et al. American Society for Transplantation and Cellular Therapy Series: #3-Prevention of cytomegalovirus infection and disease after hematopoietic cell transplantation. Transplant Cell Ther. 2021;27(9):707–719. doi: 10.1016/j.jtct.2021.05.001.
   PubMedGoogle Scholar
• Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV. National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America. [cited 2022 Sep 19]. Available from: https://clinicalinfo.hiv.gov/en/guidelines/adult-andadolescent-opportunistic-infection
   Google Scholar
• Institute of Medicine (US). Committee to study priorities for vaccine development: vaccines for the 21st century: a tool for decisionmaking. Stratton KR, Durch JS, Lawrence RS, editor. Washington (DC): National Academies Press; 2000.
   Google Scholar
• Albright CM, Werner EF, Hughes BL. Cytomegalovirus screening in pregnancy: a cost-effectiveness and threshold analysis. Am J Perinatol. 2019;36(7):678–687. doi: 10.1055/s-0038-1676495.
   PubMed Web of Science ®Google Scholar
• Walter E, Brennig C, Schöllbauer V, et al. How to save money: congenital CMV infection and the economy. In: Halwachs-Baumann G, editor. Congenital cytomegalovirus infection: epidemiology, diagnosis, therapy. Cham (Switzerland): Springer International Publishing; 2018. p. 121–144.
   Google Scholar
• Meyers J, Sinha A, Samant S, et al. The economic burden of congenital cytomegalovirus disease in the first year of life: a retrospective analysis of health insurance claims data in the United States. Clin Ther. 2019;41(6):1040 e1043–1056 e1043. doi: 10.1016/j.clinthera.2019.04.022.
   Web of Science ®Google Scholar
• Inagaki K, Blackshear C, Palmer A, et al. Risk factors, geographic distribution, and healthcare burden of symptomatic congenital cytomegalovirus infection in the United States: analysis of a nationally representative database, 2000-2012. J Pediatr. 2018;199:118.e111–123.e111. doi: 10.1016/j.jpeds.2018.03.036.
   Web of Science ®Google Scholar
• Grossberg LB, Ezaz G, Grunwald D, et al. A national survey of the prevalence and impact of cytomegalovirus infection among hospitalized patients with ulcerative colitis. J Clin Gastroenterol. 2018;52(3):241–245. doi: 10.1097/MCG.0000000000000736.
   PubMed Web of Science ®Google Scholar
• Lucas A, Sinha A, Fowler KB, et al. A framework for assessing the lifetime economic burden of congenital cytomegalovirus in the United States. Cost Eff Resour Alloc. 2019;17:21. doi: 10.1186/s12962-019-0189-0.
   PubMed Web of Science ®Google Scholar
• Lanzieri TM, Bialek SR, Bennett MV, et al. Cytomegalovirus infection among infants in California neonatal intensive care units, 2005–2010. J Perinat Med. 2014;42(3):393–399. doi: 10.1515/jpm-2013-0183.
   PubMed Web of Science ®Google Scholar
• Tran C, Bennett MV, Gould JB, et al. Cytomegalovirus infection among infants in neonatal intensive care units, California, 2005 to 2016. Am J Perinatol. 2020;37(2):146–150. doi: 10.1055/s-0039-1683958.
   PubMed Web of Science ®Google Scholar
• Korndewal MJ, Weltevrede M, van den Akker-van Marle ME, et al. Healthcare costs attributable to congenital cytomegalovirus infection. Arch Dis Child. 2018;103(5):452–457. doi: 10.1136/archdischild-2017-312805.
   PubMed Web of Science ®Google Scholar
• Retzler J, Hex N, Bartlett C, et al. Economic cost of congenital CMV in the UK. Arch Dis Child. 2019;104(6):559–563. doi: 10.1136/archdischild-2018-316010.
   PubMed Web of Science ®Google Scholar
• Ahmed I, Kassem W, Salam Y, et al. Outcome of cytomegalovirus colitis in inflammatory bowel disease with different regimes of ganciclovir. Middle East J Dig Dis. 2018;10(4):220–229. doi: 10.15171/mejdd.2018.114.
   PubMedGoogle Scholar
• Delvincourt M, Lopez A, Pillet S, et al. The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease. Aliment Pharmacol Ther. 2014;39(7):712–720. doi: 10.1111/apt.12650.
   PubMed Web of Science ®Google Scholar
• Touhami S, Qu L, Angi M, et al. Cytomegalovirus anterior uveitis: clinical characteristics and long-term outcomes in a French series. Am J Ophthalmol. 2018;194:134–142. doi: 10.1016/j.ajo.2018.07.021.
   PubMed Web of Science ®Google Scholar
• Saletinger R, Poljak M, Strle F. Presence of human cytomegalovirus DNA in blood of patients with community-acquired pneumonia. Clin Microbiol Infect. 2015;21(1):97–102. doi: 10.1016/j.cmi.2014.09.001.
   PubMed Web of Science ®Google Scholar
• Vergara A, Cilloniz C, Luque N, et al. Detection of human cytomegalovirus in bronchoalveolar lavage of intensive care unit patients. Eur Respir J. 2018;51(2):1701332. doi: 10.1183/13993003.01332-2017.
   PubMed Web of Science ®Google Scholar
• Jedlińska-Pijanowska D, Czech-Kowalska J, Kłodzińska M, et al. Antiviral treatment in congenital HCMV infection: the six-year experience of a single neonatal center in Poland. Adv Clin Exp Med. 2020;29(10):1161–1167. doi: 10.17219/acem/125427.
   PubMed Web of Science ®Google Scholar
• Maconi G, Lombardini M, Furfaro F, et al. Long-term outcome of inflammatory bowel diseases with cytomegalovirus colitis: effect of antiviral treatment. Eur J Gastroenterol Hepatol. 2014;26(10):1146–1151. doi: 10.1097/MEG.0000000000000175.
   PubMed Web of Science ®Google Scholar
• Aoki H, Kitano T, Kitagawa D. Disease burden of congenital cytomegalovirus infection in Japan. J Infect Chemother. 2021;27(2):161–164. doi: 10.1016/j.jiac.2020.08.018.
   PubMed Web of Science ®Google Scholar
• Maeda T, Babazono A, Nishi T, et al. The impact of opportunistic infections on clinical outcome and healthcare resource uses for adult T cell leukaemia. PLoS One. 2015;10(8):e0135042. doi: 10.1371/journal.pone.0135042.
   PubMed Web of Science ®Google Scholar
• Lin C, Tomio J, Tanaka H, et al. Diagnosis and medical care for congenital cytomegalovirus infection: an observational study using claims data in Japan, 2010 to 2017. Medicine. 2020;99(10):e19419. doi: 10.1097/MD.0000000000019419.
   PubMed Web of Science ®Google Scholar
• Niz Xavier PC, Gonçalves Vieira P, de Souza Arantes T, et al. Cytomegalovirus identification in blood and urine of newborns by nested polymerase chain reaction. West Indian Med J. 2015;65(2):291–294. doi: 10.7727/wimj.2014.378.
   PubMed Web of Science ®Google Scholar
• Yamamoto AY, Mussi-Pinhata MM, Isaac Mde L, et al. Congenital cytomegalovirus infection as a cause of sensorineural hearing loss in a highly immune population. Pediatr Infect Dis J. 2011;30(12):1043–1046. doi: 10.1097/INF.0b013e31822d9640.
   PubMed Web of Science ®Google Scholar
• Marin LJ, Santos de Carvalho Cardoso E, Bispo Sousa SM, et al. Prevalence and clinical aspects of CMV congenital infection in a low-income population. Virol J. 2016;13(1):148–148. doi: 10.1186/s12985-016-0604-5.
   PubMed Web of Science ®Google Scholar
• Lachance P, Chen J, Featherstone R, et al. Association between cytomegalovirus reactivation and clinical outcomes in immunocompetent critically ill patients: a systematic review and Meta-Analysis. Open Forum Infect Dis. 2017;4(2):ofx029. doi: 10.1093/ofid/ofx029.
   PubMed Web of Science ®Google Scholar
• Li X, Huang Y, Xu Z, et al. Cytomegalovirus infection and outcome in immunocompetent patients in the intensive care unit: a systematic review and meta-analysis. BMC Infect Dis. 2018;18(1):289. doi: 10.1186/s12879-018-3195-5.
   PubMed Web of Science ®Google Scholar
• Bergevin A, Zick CD, McVicar SB, et al. Cost-benefit analysis of targeted hearing directed early testing for congenital cytomegalovirus infection. Int J Pediatr Otorhinolaryngol. 2015;79(12):2090–2093. doi: 10.1016/j.ijporl.2015.09.019.
   PubMed Web of Science ®Google Scholar
• Gantt S, Dionne F, Kozak FK, et al. Cost-effectiveness of universal and targeted newborn screening for congenital cytomegalovirus infection. JAMA Pediatr. 2016;170(12):1173–1180. doi: 10.1001/jamapediatrics.2016.2016.
   PubMed Web of Science ®Google Scholar
• Dempsey AF, Pangborn HM, Prosser LA. Cost-effectiveness of routine vaccination of adolescent females against cytomegalovirus. Vaccine. 2012;30(27):4060–4066. doi: 10.1016/j.vaccine.2012.04.011.
   PubMed Web of Science ®Google Scholar
• N’Diaye DS, Launay O, Picone O, et al. Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France. Vaccine. 2018;36(10):1285–1296. doi: 10.1016/j.vaccine.2018.01.042.
   PubMed Web of Science ®Google Scholar
• Williams EJ, Gray J, Luck S, et al. First estimates of the potential cost and cost saving of protecting childhood hearing from damage caused by congenital CMV infection. Arch Dis Child Fetal Neonatal Ed. 2015;100(6):F501–506. doi: 10.1136/archdischild-2014-306756.
   PubMed Web of Science ®Google Scholar
• Beswick R, David M, Higashi H, et al. Integration of congenital cytomegalovirus screening within a newborn hearing screening programme. J Paediatr Child Health. 2019;55(11):1381–1388. doi: 10.1111/jpc.14428.
   PubMed Web of Science ®Google Scholar
• Grosse SD, Dollard SC, Ortega-Sanchez IR. Economic assessments of the burden of congenital cytomegalovirus infection and the cost-effectiveness of prevention strategies. Semin Perinatol. 2021;45(3):151393. doi: 10.1016/j.semperi.2021.151393.
   PubMed Web of Science ®Google Scholar
• Kadambari S, Pollard AJ, Goldacre MJ, et al. Congenital viral infections in England over five decades: a population-based observational study. Lancet Infect Dis. 2020;20(2):220–229. doi: 10.1016/S1473-3099(19)30416-5.
   PubMed Web of Science ®Google Scholar
• Grosse SD, Leung J, Lanzieri TM. Identification of congenital CMV cases in administrative databases and implications for monitoring prevalence, healthcare utilization, and costs. Curr Med Res Opin. 2021;37(5):769–779. doi: 10.1080/03007995.2021.1890556.
   PubMed Web of Science ®Google Scholar